Under E6 -

The International Council for Harmonisation (ICH) recently finalized the guideline, which entered into force in July 2025. This update represents a major shift toward digital-first, risk-proportional clinical research.

E6(R3) emphasizes building quality into the trial design from the start, rather than relying on retrospective checking. under e6

Monitoring and oversight are now scaled based on the actual risks of a trial. Low-risk aspects should not be overburdened with unnecessary bureaucracy. under e6